WAKIX Trademark

Trademark Overview

On Wednesday, June 25, 2014, a trademark application was filed for WAKIX with the United States Patent and Trademark Office. The USPTO has given the WAKIX trademark a serial number of 79150074. The federal status of this trademark filing is SECTION 71 ACCEPTED as of Thursday, March 11, 2021. This trademark is owned by BIOPROJET EUROPE LTD. The WAKIX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for the treatment of narcolepsy or other sleep disorders
wakix

General Information

Serial Number79150074
Word MarkWAKIX
Filing DateWednesday, June 25, 2014
Status706 - SECTION 71 ACCEPTED
Status DateThursday, March 11, 2021
Registration Number4680400
Registration DateTuesday, February 3, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 18, 2014

Trademark Statements

Goods and ServicesPharmaceutical products for the treatment of narcolepsy or other sleep disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, August 4, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBIOPROJET EUROPE LIMITED
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressIE
Party NameBIOPROJET EUROPE LTD
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressIE
Party NameBIOPROJET EUROPE LTD
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressIE

Trademark Events

Event DateEvent Description
Thursday, July 31, 2014SN ASSIGNED FOR SECT 66A APPL FROM IB
Wednesday, October 29, 2014NOTICE OF PUBLICATION
Monday, August 4, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 8, 2014APPLICATION FILING RECEIPT MAILED
Thursday, October 2, 2014ASSIGNED TO EXAMINER
Wednesday, October 8, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 11, 2019CHANGE OF NAME/ADDRESS REC'D FROM IB
Wednesday, October 29, 2014NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, October 29, 2014NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Friday, November 14, 2014NOTIFICATION PROCESSED BY IB
Tuesday, November 18, 2014PUBLISHED FOR OPPOSITION
Tuesday, February 3, 2015REGISTERED-PRINCIPAL REGISTER
Thursday, March 5, 2015GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, March 10, 2015FINAL DISPOSITION PROCESSED
Tuesday, March 10, 2015FINAL DISPOSITION NOTICE SENT TO IB
Friday, March 27, 2015NOTIFICATION PROCESSED BY IB
Saturday, February 3, 2024COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Friday, January 15, 2021TEAS SECTION 71 RECEIVED
Wednesday, February 17, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, March 11, 2021REGISTERED-SEC.71 ACCEPTED
Thursday, March 11, 2021NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Friday, August 30, 2024NEW REPRESENTATIVE AT IB RECEIVED
Friday, July 12, 2024INTERNATIONAL REGISTRATION RENEWED

Related Keywords

wakix sleep disorders other narcolepsy products treatment pharmaceutical